In the scientific trial working experience with Xyrem in narcolepsy/cataplexy people at therapeutic doses, two patients claimed anxiety and one described insomnia next abrupt discontinuation with the termination of the scientific trial; in the two patients with stress, the frequency of cataplexy had enhanced markedly at the same time.Numerous econo